Di Mauro Paola, La Mantia Ignazio, Cocuzza Salvatore, Sciancalepore Pasqua Irene, Rasà Deborak, Maniaci Antonino, Ferlito Salvatore, Tundo Isabella, Anzivino Roberta
Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", ENT Section, A.O.U. Policlinico "G.Rodolico-San Marco", University of Catania, Catania, Italy.
Centre of Phoniatry and Rehabilitation of Communication Disorders - Azienda Sanitaria Locale Lecce, Lecce, Italy.
Front Med (Lausanne). 2022 Jan 6;8:790931. doi: 10.3389/fmed.2021.790931. eCollection 2021.
The aim of this study was to present some cases of acute vertigo potentially related to the coronavirus disease 2019 (COVID-19) vaccine and review the available literature about cochleovestibular dysfunction after the COVID-19 vaccination. In the period from May to July 2021, we evaluated 33 patients (mean age 54.3 ± 14.1) with "acute vertigo" post COVID-19 vaccination. A detailed medical history was taken on comorbidities, types of vaccines received, and symptoms associated. All patients underwent otoneurological evaluation, such as head impulse test, nystagmus evaluation, test of skew (HINTS) examination. Head shaking test-induced nystagmus, hyperventilation-induced nystagmus, and parossistic positional nystagmus were studied to search for vestibular impairment. Symptoms included 16 patients (48.5%) with objective vertigo, 14 patients (42.4%) with subjective vertigo, and 3 patients (9.1%) with dizziness. Of the associated ear, nose, and throat (ENT) symptoms, the most expressed was tinnitus (18.2%). Bedside examination showed absent nystagmus in 7 patients (21.2%), 9 patients (27.3%) had horizontal or rotatory nystagmus, 17 patients (51.5%) had a vertical or oblique nystagmus, negative HST, or "central HINTS." The 9 patients had an evoked nystagmus pathognomonic for benign paroxysmal positional vertigo; in the remaining 17 cases, peripheral vestibular dysfunction could be excluded and central disorder may be suggested. Due to the prevalence of nystagmus of non-peripheral origin, a central nervous system involvement could not be excluded. However, due to the small sample size, a definite cause-effect relationship between vaccination and vertigo cannot be inferred. In light of expected third dose, large-scale and well-designed studies are needed to better define possible adverse reactions of the COVID-19 vaccine.
本研究的目的是呈现一些可能与2019冠状病毒病(COVID-19)疫苗相关的急性眩晕病例,并回顾有关COVID-19疫苗接种后耳蜗前庭功能障碍的现有文献。在2021年5月至7月期间,我们评估了33例(平均年龄54.3±14.1岁)接种COVID-19疫苗后出现“急性眩晕”的患者。详细询问了合并症、所接种疫苗的类型以及相关症状的病史。所有患者均接受了耳神经学评估,如摇头试验、眼球震颤评估、偏斜试验(HINTS)检查。研究了摇头试验诱发的眼球震颤、过度换气诱发的眼球震颤和阵发性位置性眼球震颤,以寻找前庭功能障碍。症状包括16例(48.5%)有客观性眩晕、14例(42.4%)有主观性眩晕和3例(9.1%)有头晕。在相关的耳鼻喉(ENT)症状中,最常见的是耳鸣(18.2%)。床边检查显示7例(21.2%)患者无眼球震颤,9例(27.3%)有水平或旋转性眼球震颤,17例(51.5%)有垂直或斜向眼球震颤、摇头试验阴性或“中枢性HINTS”。9例患者有良性阵发性位置性眩晕的诱发眼球震颤特征;在其余17例中,可以排除外周前庭功能障碍,可能提示中枢性疾病。由于非外周性眼球震颤的普遍性,不能排除中枢神经系统受累。然而,由于样本量小,无法推断疫苗接种与眩晕之间明确的因果关系。鉴于预计会接种第三剂疫苗,需要开展大规模且设计良好的研究,以更好地确定COVID-19疫苗可能的不良反应。